V2 Financial group’s AbbVie ABBV Stock Holding History

V2 Financial group’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Sell	8,694 -13	-0.1%	-$2.88K	0.88%	19
2025 Q4	$1.99M	Sell	8,707 -20	-0.2%	-$4.56K	0.98%	17
2025 Q3	$2.02M	Sell	8,727 -1	-0%	-$204	1.12%	11
2025 Q2	$1.62M	Hold	8,728	–	–	0.98%	15
2025 Q1	$1.83M	Hold	8,728	–	–	1.18%	13
2024 Q4	$1.55M	Hold	8,728	–	–	0.94%	19
2024 Q3	$1.72M	Hold	8,728	–	–	1.11%	16
2024 Q2	$1.59M	Sell	8,728 -19	-0.2%	-$3.15K	1.06%	16
2024 Q1	$1.59M	Sell	8,747 -2,166	-20%	-$373K	1.09%	15
2023 Q4	$1.69M	Hold	10,913	–	–	1.18%	14
2023 Q3	$1.63M	Buy	10,913 +350	+3%	+$51.4K	1.22%	14
2023 Q2	$1.42M	Buy	10,563 +22	+0.2%	+$3.23K	1.02%	14
2023 Q1	$1.68M	Hold	10,541	–	–	1.21%	11
2022 Q4	$1.7M	Hold	10,541	–	–	1.35%	12
2022 Q3	$1.41M	Hold	10,541	–	–	1.24%	14
2022 Q2	$1.61M	Buy	+10,541	New	+$1.61M	1.3%	12
2021 Q1	–	Sell	-5,836	Closed	-$625K	–	57
2020 Q4	$625K	Buy	+5,836	New	+$561K	0.63%	24

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

V2 Financial group's ABBV Position: Q1 2026 in Review

V2 Financial group reduced its AbbVie (ABBV) stake by 0.15% in Q1 2026, selling an estimated $2.88K and leaving 8,694 shares worth $1.89M. The position accounts for 0.88% of the portfolio, ranked #19.

V2 Financial group first reported a position in ABBV in Q4 2020 and has held it in 17 quarters since. The position peaked at $2.02M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

V2 Financial group held 8,694 shares of AbbVie worth $1.89M as of Q1 2026.
V2 Financial group sold 13 AbbVie shares in Q1 2026, an estimated $2.88K.
AbbVie made up 0.88% of V2 Financial group's portfolio in Q1 2026, its #19 holding.
V2 Financial group first reported a position in AbbVie in Q4 2020 and has held it in 17 quarters since.
V2 Financial group's AbbVie position peaked at $2.02M in Q3 2025.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on V2 Financial group's 13F filing for Q1 2026, filed 4 May 2026.